BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24159155)

  • 1. Metronidazole increases the emergence of ciprofloxacin- and amikacin-resistant Pseudomonas aeruginosa by inducing the SOS response.
    Hocquet D; Bertrand X
    J Antimicrob Chemother; 2014 Mar; 69(3):852-4. PubMed ID: 24159155
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin-Mediated Mutagenesis Is Suppressed by Subinhibitory Concentrations of Amikacin in Pseudomonas aeruginosa.
    Valencia EY; Esposito F; Spira B; Blázquez J; Galhardo RS
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
    Sener B; Hayran M; Kocagöz T; Ustaçelebi S
    Mikrobiyol Bul; 1990 Apr; 24(2):120-5. PubMed ID: 2128529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin.
    Cirz RT; O'Neill BM; Hammond JA; Head SR; Romesberg FE
    J Bacteriol; 2006 Oct; 188(20):7101-10. PubMed ID: 17015649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa.
    Blázquez J; Gómez-Gómez JM; Oliver A; Juan C; Kapur V; Martín S
    Mol Microbiol; 2006 Oct; 62(1):84-99. PubMed ID: 16956383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the rates of antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa between 2002 and 2004 in a tertiary-care teaching hospital in Turkey.
    Işeri L; Bayraktar MR
    New Microbiol; 2008 Jul; 31(3):351-5. PubMed ID: 18843889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion of Pseudomonas aeruginosa to collagen biomaterials: effect of amikacin and ciprofloxacin on the colonization and survival of the adherent organisms.
    Trafny EA; Kowalska K; Grzybowski J
    J Biomed Mater Res; 1998 Sep; 41(4):593-9. PubMed ID: 9697032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of quinolones on gene expression and bacterial membranes.
    Dalhoff A; Döring G
    Antibiot Chemother (1971); 1987; 39():205-14. PubMed ID: 2823690
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
    Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
    Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SOS response increases bacterial fitness, but not evolvability, under a sublethal dose of antibiotic.
    Torres-Barceló C; Kojadinovic M; Moxon R; MacLean RC
    Proc Biol Sci; 2015 Oct; 282(1816):20150885. PubMed ID: 26446807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
    Kalai S; Jouaihia W; Mahjoubi F; Ghozzi R; Thabet L; Ben Rejeb S; Hammami A; Kechrid A; Ben Hassen A
    Tunis Med; 2004 Dec; 82(12):1070-4. PubMed ID: 15822507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of preincubation of Pseudomonas aeruginosa in subinhibitory concentrations of amikacin, ceftazidime and ciprofloxacin on adherence to plastic catheters.
    Martínez-Martínez L; Pascual A; Perea EJ
    Chemotherapy; 1991; 37(1):62-5. PubMed ID: 1901544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellou H; Petrikkos G
    Antimicrob Agents Chemother; 1987 Jun; 31(6):959-61. PubMed ID: 3113330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimization of antibiotics in combination].
    Zhang LH; Wang LF; Meng ZY; Yu QP; Gao BQ; Ba T; Wang XD; Ma WH; Li YY; Zhang J
    Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):93-6. PubMed ID: 18785405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
    Vojtová V; Kolár M; Hricová K; Uvízl R; Neiser J; Blahut L; Urbánek K
    New Microbiol; 2011 Jul; 34(3):291-8. PubMed ID: 21811750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.